Hello, Fool! | Login | Signup | My Fool
Jul 24, 2008 9:23 AM ET | Site Changes | Help
A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.
View Ticker Page (EXEL)
Results 41 - 50 of 351 : 12345Next »
Recs
11x (< 20) Submitted: 4/05/07 1:22 PM : Start Price: $10.50 EXEL Score: 25.08
You don't buy stocks just because they have a big pipeline of variouis drugs in Phase I, II. At least wait until one has positive Phase III and submits for FDA approval. This is too early in the game and results have not been impressive so far.
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
TMFselzhanik (95.03) Submitted: 4/25/07 11:37 AM : Start Price: $8.85 EXEL Score: -19.34
My unborn daughter had some fantastic points about the stock:http://www.votigo.com/contests/showentry/2985Despite my concerns that they are bleeding cash at $10 million per month, she assures me that the expenses are primarily going into R&D, and ...
redbird67 (67.33) Submitted: 8/23/06 5:38 PM : Start Price: $8.10 EXEL Score: -16.20
Appears to have smart management. Uses development partnerships to spread the risk (and costs). Relationships with some large drug companies that have skinny 'pipes'. Phase 2 trials of several drugs in advanced stages. Appear hopeful. Focusing on...
TDJ1 (< 20) Submitted: 8/23/06 9:10 PM : Start Price: $8.28 EXEL Score: -17.54
This one might take a couple years to show fruit. But, when EXEL begins to excel, it will produce more than enough fruit to make up for the lean years. Get in now and wait for the 20-bagger.
Report this Post Replies: 1 | Reply | Permalink
TMFSunshine (< 20) Submitted: 4/18/06 12:16 AM : Start Price: $10.45 EXEL Score: -35.95
check out the pipeline on that company!
spinbob7 (57.68) Submitted: 6/16/06 12:08 AM : Start Price: $10.56 EXEL Score: -38.91
Very deep pipeline and good partnerships will allow this young biotech to bring numerous drugs to market beginning around 2010.
sowfar (20.57) Submitted: 6/08/06 2:50 PM : Start Price: $10.37 EXEL Score: -37.55
EXEL has a big pipeline of cancer drugs. Steady flow of news likely. Biotech is out of favour as of writing. Company's management seems good and has long-term outlook. Connections with big pharma.
whodey007 (72.77) Submitted: 1/12/07 6:05 PM : Start Price: $10.13 EXEL Score: -23.47
It's only a matter of time before this stock takes off!
LeoFender (< 20) Submitted: 8/18/06 6:30 PM : Start Price: $8.48 EXEL Score: -19.61
With solid results in the pipeline, EXEL seems poised to post profit around 2010.
msamet1 (98.72) Submitted: 3/30/07 10:17 AM : Start Price: $9.95 EXEL Score: 22.62
Midstage clinical targets have proven to be ineffective in widely treating cancers
Terms & Conditions
RSS Headlines
Fool UK